Medline Inc. (MDLN) Shareholder Equity
- 2026-06-27: Preferred Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $11.40B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-6.00M; Retained Earnings (Accumulated Deficit)USD $182.00M.
- 2026-03-28: Preferred Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $11.13B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $18.00M; Retained Earnings (Accumulated Deficit)USD $122.00M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $10.72B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $27.00M; Retained Earnings (Accumulated Deficit)USD $-7.00M.
- 2025-12-16: Preferred Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m); Retained Earnings (Accumulated Deficit)USD (m).
Medline Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Partners' Capital USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD | Partners' Capital Account, Contributions USD | Partners' Capital Account, Exchanges and Conversions USD | Partners' Capital Account, Redemptions USD | Partners' Capital Account, Unit-based Payment Arrangement, Amount USD | Partners' Capital Account, Distributions USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $0.00 | $11.40B | $-6.00M | $182.00M | $11.57B | $19.08B | (m) | 3 month · $29.00M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $10.00M |
| 2026-03-28 | $0.00 | $11.13B | $18.00M | $122.00M | $11.27B | $19.35B | (m) | 3 month · $22.00M | 3 month · $0.00 | (m) | (m) | (m) | (m) | (m) | 3 month · $10.00M |
| 2025-12-31 | $0.00 | $10.72B | $27.00M | $-7.00M | $10.74B | $19.29B | (m) | $6.00M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $86.00M |
| 2025-12-16 | (m) | (m) | (m) | (m) | (m) | (m) | $16.87B | (m) | (m) | (m) | 11 month · $10.00M | (m) | 11 month · $59.00M | 11 month · $510.00M | (m) |
| 2025-06-28 | (m) | (m) | (m) | (m) | (m) | (m) | $16.58B | (m) | (m) | (m) | (m) | (m) | 3 month · $14.00M | 3 month · $299.00M | 3 month · $23.00M |
| 2025-03-29 | (m) | (m) | (m) | (m) | (m) | (m) | $16.49B | (m) | (m) | (m) | 3 month · $10.00M | (m) | 3 month · $16.00M | (m) | 3 month · $22.00M |
| 2024-12-31 | (m) | (m) | $11.00M | (m) | (m) | (m) | $16.16B | (m) | (m) | (m) | 12 month · $9.00M | 12 month · $57.00M | 12 month · $53.00M | 12 month · $1.50B | 12 month · $165.00M |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $16.74B | (m) | (m) | 12 month · $84.00M | (m) | 12 month · $37.00M | 12 month · $70.00M | 12 month · $114.00M | 12 month · $162.00M |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $16.62B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |